Stock Analysis: Decent Value Stocks

Fundamental Rating

Overall EXEL gets a fundamental rating of 7 out of 10. We evaluated EXEL against 568 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making EXEL a very profitable company, without any liquidiy or solvency issues. EXEL is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, EXEL could be worth investigating further for value and growth and quality investing!.

1. Profitability

1.1 Basic Checks

In the past year EXEL was profitable.

In the past year EXEL had a positive cash flow from operations.

Each year in the past 5 years EXEL has been profitable.

EXEL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

EXEL has a better Return On Assets (15.77%) than 98.23% of its industry peers.

Looking at the Return On Equity, with a value of 20.52%, EXEL belongs to the top of the industry, outperforming 97.35% of the companies in the same industry.

The Return On Invested Capital of EXEL (18.78%) is better than 97.88% of its industry peers.

The Average Return On Invested Capital over the past 3 years for EXEL is significantly below the industry average of 13.59%.

The last Return On Invested Capital (18.78%) for EXEL is above the 3 year average (7.03%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	15.77%
ROE	20.52%
ROIC	18.78%

ROA(3y)7.28%

ROA(5y)8.82%

ROE(3y)8.99%

ROE(5y)10.39%

ROIC(3y)7.03%

ROIC(5y)8.48%

1.3 Margins

With an excellent Profit Margin value of 22.43%, EXEL belongs to the best of the industry, outperforming 97.52% of the companies in the same industry.

In the last couple of years the Profit Margin of EXEL has declined.

EXEL has a Operating Margin of 29.22%. This is amongst the best in the industry. EXEL outperforms 98.58% of its industry peers.

EXEL's Operating Margin has declined in the last couple of years.

The Gross Margin of EXEL (96.25%) is better than 96.64% of its industry peers.

In the last couple of years the Gross Margin of EXEL has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	29.22%
PM (TTM)	22.43%
GM	96.25%

OM growth 3Y-5.74%

OM growth 5Y-28.9%

PM growth 3Y0.09%

PM growth 5Y-32.47%

GM growth 3Y-0.1%

GM growth 5Y-0.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EXEL is still creating some value.

EXEL has less shares outstanding than it did 1 year ago.

EXEL has more shares outstanding than it did 5 years ago.

There is no outstanding debt for EXEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

EXEL has an Altman-Z score of 10.23. This indicates that EXEL is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of EXEL (10.23) is better than 86.90% of its industry peers.

There is no outstanding debt for EXEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	10.23

ROIC/WACC1.58

WACC11.91%

2.3 Liquidity

EXEL has a Current Ratio of 3.93. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.

With a Current ratio value of 3.93, EXEL perfoms like the industry average, outperforming 46.37% of the companies in the same industry.

A Quick Ratio of 3.88 indicates that EXEL has no problem at all paying its short term obligations.

EXEL has a Quick ratio (3.88) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	3.93
Quick Ratio	3.88

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 485.71% over the past year.

The earnings per share for EXEL have been decreasing by -14.85% on average. This is quite bad

The Revenue has grown by 17.31% in the past year. This is quite good.

The Revenue has been growing by 16.47% on average over the past years. This is quite good.

EPS 1Y (TTM)485.71%

EPS 3Y22.28%

EPS 5Y-14.85%

EPS Q2Q%N/A

Revenue 1Y (TTM)17.31%

Revenue growth 3Y22.83%

Revenue growth 5Y16.47%

Sales Q2Q%14.33%

3.2 Future

EXEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.97% yearly.

The Revenue is expected to grow by 10.44% on average over the next years. This is quite good.

EPS Next Y171.3%

EPS Next 2Y64.39%

EPS Next 3Y52.07%

EPS Next 5Y40.97%

Revenue Next Year18.02%

Revenue Next 2Y9.45%

Revenue Next 3Y10.03%

Revenue Next 5Y10.44%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

EXEL is valuated rather expensively with a Price/Earnings ratio of 20.30.

95.58% of the companies in the same industry are more expensive than EXEL, based on the Price/Earnings ratio.

When comparing the Price/Earnings ratio of EXEL to the average of the S&P500 Index (27.73), we can say EXEL is valued slightly cheaper.

With a Price/Forward Earnings ratio of 19.25, EXEL is valued on the expensive side.

95.04% of the companies in the same industry are more expensive than EXEL, based on the Price/Forward Earnings ratio.

EXEL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.83.

		Industry Rank	Sector Rank
PE	20.3
Fwd PE	19.25

4.2 Price Multiples

EXEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EXEL is cheaper than 96.99% of the companies in the same industry.

EXEL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EXEL is cheaper than 96.28% of the companies in the same industry.